stem cells in their environment

team >

oliver culley




PhD Student


BSc (Hons) Biomedical Sciences with Industrial Experience, University of Manchester


[Full PubMed List]

•  ‘Common genetic variation drives molecular heterogeneity in human iPSCs.’ Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S, Bala S, Bensaddek D, Casale FP, Culley OJ, Danecek P, Faulconbridge A, Harrison PW, Kathuria A, McCarthy D, McCarthy SA, Meleckyte R, Memari Y, Moens N, Soares F, Mann A, Streeter I, Agu CA, Alderton A, Nelson R, Harper S, Patel M, White A, Patel SR, Clarke L, Halai R, Kirton CM, Kolb-Kokocinski A, Beales P, Birney E, Danovi D, Lamond AI, Ouwehand WH, Vallier L, Watt FM, Durbin R, Stegle O, Gaffney DJ. Nature. 2017 May 10. doi: 10.1038/nature22403 PMID: 28489815 [PubMed]

•  'A high-content platform to characterise human induced pluripotent stem cell lines.' Leha A, Moens N, Meleckyte R, Culley OJ, Gervasio MK, Kerz M, Reimer A, Cain SA, Streeter I, Folarin A, Stegle O, Kielty CM; HipSci Consortium, Durbin R, Watt FM, Danovi D. Methods. 2015 Nov 25. pii: S1046-2023(15)30153-5. doi: 10.1016/j.ymeth.2015.11.012. PMID: 26608109 [PubMed]

•  'Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility.' Sevlever D, Zou F, Ma L, Carrasquillo S, Crump MG, Culley OJ, Hunter TA, Bisceglio GD, Younkin L, Allen M, Carrasquillo MM, Sando SB, Aasly JO, Dickson DW, Graff-Radford NR, Petersen RC; Morgan K for ARUK consortium, Belbin O. Mol Neurodegener. 2015 Apr 9;10:18. doi: 10.1186/s13024-015-0015-x. [PubMed]

•  'Human pluripotent stem cells on artificial microenvironments: a high content perspective.' Viswanathan P, Gaskell T, Moens N, Culley OJ, Hansen D, Gervasio MK, Yeap YJ, Danovi D. Front Pharmacol. 2014 Jul 2;5:150. doi: 10.3389/fphar.2014.00150. eCollection 2014. PMID: 25071572 [PubMed]

•  'Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology.' Zou F, Belbin O, Carrasquillo MM, Culley OJ, Hunter TA, Ma L, Bisceglio GD, Allen M, Dickson DW, Graff-Radford NR, Petersen RC; Genetic and Environmental Risk for Alzheimer's disease (GERAD1) Consortium, Morgan K, Younkin SG. PLoS One. 2013 May 28;8(5):e64802. doi: 10.1371/journal.pone.0064802. PMID: 23724096 [PubMed]

•  'Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease.' Belbin O, Carrasquillo MM, Crump M, Culley OJ, Hunter TA, Ma L, Bisceglio G, Zou F, Allen M, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG. Hum Genet. 2011 Mar;129(3):273-82. doi: 10.1007/s00439-010-0924-2. PMID: 21132329 [PubMed]

•  'Association and heterogeneity at the GAPDH locus in Alzheimer's disease.' Allen M, Cox C, Belbin O, Ma L, Bisceglio GD, Wilcox SL, Howell CC, Hunter TA, Culley O, Walker LP, Carrasquillo MM, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG, Ertekin-Taner N. Neurobiol Aging. 2012 Jan;33(1):203.e25-33. doi: 10.1016/j.neurobiolaging.2010.08.002. PMID: 20864222 [PubMed]